MIR3133

Across TCGA pan-cancer cohorts, MIR3133 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR3133 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR3133 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3133 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

LIHC, DLBC, and SKCM are the cancer types where MIR3133 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.193	0.695	<.001	108	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	63	view →
SKCM	DFS	Tertile	II,III,IV	0.683	0.532	.003	50	view →
LUAD	DFS	Tertile	All	0.606	0.262	.001	39	view →
ACC	OS	Tertile	II,III,IV	0.348	0.812	.005	36	view →
KICH	DFS	Tertile	III,IV	0.061	0.788	.009	27	view →
PAAD	DFS	Tertile	II,III,IV	0.311	0.479	.014	27	view →
LUSC	DFS	Tertile	III,IV	0.152	0.781	.004	27	view →
OV	OS	Quartile	IV	0.239	0.437	.015	22	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
UCEC	DFS	Tertile	All	0.406	0.659	.010	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR3133–LIHC (OS)

Open the LIHC breakdown →